Paweł P Liberski Selected Research

Kuru

1/2019	Kuru, the First Human Prion Disease.
1/2012	Kuru: the first prion disease.
1/2004	Kuru: a half-opened window onto the landscape of neurodegenerative diseases.
1/2004	Amyloid plaques in transmissible spongiform encephalopathies (prion diseases).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paweł P Liberski Research Topics

Disease

8	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2019 - 01/2002
6	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 01/2012 - 01/2002
5	Neoplasms (Cancer) 05/2022 - 01/2004
4	Kuru 01/2019 - 01/2004
4	Infections 12/2014 - 01/2004
3	Amyloid Plaque 01/2019 - 01/2009
3	Ependymoma 01/2016 - 01/2003
3	Alzheimer Disease (Alzheimer's Disease) 01/2012 - 01/2005
2	Glioblastoma (Glioblastoma Multiforme) 05/2022 - 05/2011
2	Acquired CJD 01/2012 - 01/2004
2	Cognitive Dysfunction 01/2012 - 01/2005
1	Demyelinating Diseases (Demyelinating Disease) 01/2022
1	Torticollis (Wryneck) 01/2022
1	Vertigo (Positional Vertigo) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 11/2017
1	Intracranial Vasospasm 11/2017
1	Chromosome Aberrations (Chromosome Abnormalities) 07/2016
1	Synucleinopathies 01/2015
1	Postmenopausal Osteoporosis 05/2013
1	Necrosis 01/2012
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2012
1	Amyloidosis 01/2008
1	Parkinson Disease (Parkinson's Disease) 01/2008
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2004
1	Brain Diseases (Brain Disorder) 01/2003

Drug/Important Bio-Agent (IBA)

7	Prion ProteinsIBA 01/2012 - 01/2003
5	Amyloid (Amyloid Fibrils)IBA 01/2015 - 01/2004
4	Codon (Codons)IBA 01/2012 - 01/2002
2	MicroRNAs (MicroRNA)IBA 06/2019 - 01/2016
2	ParaffinIBA 01/2019 - 01/2003
2	PrionsIBA 01/2012 - 01/2002
2	Valine (L-Valine)FDA Link 01/2012 - 01/2004
2	Methionine (L-Methionine)FDA Link 01/2012 - 01/2004
2	Peptides (Polypeptides)IBA 01/2012 - 01/2005
2	Proteins (Proteins, Gene)FDA Link 01/2008 - 01/2004
1	Long Noncoding RNAIBA 05/2022
1	Ion Channels (Ion Channel)IBA 01/2022
1	IsoprostanesIBA 11/2017
1	F2-Isoprostanes (F2 Isoprostanes)IBA 11/2017
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	Pyrrolidonecarboxylic Acid (Pyroglutamic Acid)IBA 01/2015
1	RNA (Ribonucleic Acid)IBA 12/2014
1	strontium ranelate (protelos)IBA 05/2013
1	Ibandronic Acid (Boniva)FDA Link 05/2013
1	3' Untranslated Regions (3' UTR)IBA 01/2012
1	Apolipoproteins E (ApoE)IBA 01/2012
1	Ferritins (Ferritin)IBA 01/2012
1	Quinolinic AcidIBA 01/2012
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2012
1	Superoxides (Superoxide)IBA 01/2012
1	Cytochrome P450 Family 46 (CYP46)IBA 01/2012
1	InterleukinsIBA 01/2012
1	HLA-DR Antigens (HLA-DR)IBA 01/2012
1	EicosanoidsIBA 01/2012
1	epidermal growth factor receptor VIIIIBA 05/2011
1	Cyclin D1IBA 01/2011
1	14-3-3 Proteins (14-3-3 Protein)IBA 09/2005
1	Complement System Proteins (Complement)IBA 01/2005
1	CytokinesIBA 01/2005
1	PrPSc ProteinsIBA 01/2004
1	SolutionsIBA 01/2004
1	Protein Isoforms (Isoforms)IBA 01/2004
1	bone mealIBA 01/2004

Therapy/Procedure

3	Therapeutics 05/2022 - 05/2011
1	Microvascular Decompression Surgery 01/2022
1	Ligation 01/2019
1	Aftercare (After-Treatment) 05/2013
1	Lasers (Laser) 01/2009
1	Blood Transfusion (Blood Transfusions) 01/2006